Drug recall · August 27, 2014
Wockhardt Metoprolol Succinate Extended-Release Tablets recall
Why: Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-count bottle (NDC 64679-737-02), b) 500-count bottle (NDC 64679-737-03) Rx only, Manufactured by: Wockhardt Limited Mumbai, India Distributed by: Wockhardt USA LLC 20 Waterview Boulevard. Parsippany, NJ 07054 USA
- Lots / codes
Lot # a) LN11005, Exp 04/15; LN11006; Exp 04/15; b) LN10979; Exp. 04/15, LN10980; Exp. 04/15
- Quantity
- 11,661 HDPE bottles
- Company
- Wockhardt Usa Inc., Parsippany, NJ
- Distribution
- Nationwide
- Initiated
- July 24, 2014 · Voluntary: Firm initiated
- Classified
- August 18, 2014
- Reported
- August 27, 2014
- Ended
- November 20, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoprolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.